What clinical criteria are necessary to diagnose Kawasaki disease?

Kawasaki disease is diagnosed based on a combination of prolonged fever and five clinical sign categories, including bilateral bulbar conjunctival injection, oropharyngeal mucosal changes, peripheral extremity changes, rash, and cervical lymphadenopathy. A diagnosis of incomplete syndrome is also valid if cardiac involvement is present even without the full set of criteria.

Which infectious diseases are differentiated from Kawasaki disease in children?

In differential diagnosis, Kawasaki syndrome must be distinguished from several childhood infections, including scarlet fever, measles, and acute viral respiratory infections.

What extracardiac visceral manifestations can occur in Kawasaki disease?

In addition to core manifestations, Kawasaki disease may present with various extracardiac and visceral changes, such as generalized lymphadenopathy, skin lesions, mucosal erosions, and gastroenterological disorders including dyspepsia, abdominal pain, and transient hepatomegaly. Rare manifestations include central nervous system involvement (aseptic meningitis), pulmonary infiltrates, and orchitis (testicular edema).

Which blood vessels are primarily affected in this disease?

The pathological process predominantly affects medium-sized arteries. Of greatest clinical significance is the severe involvement of the coronary arteries of the heart and the renal arteries.

At what age are patients most susceptible to this vasculitis?

Kawasaki disease is a classic pediatric pathology. The absolute majority of affected individuals are young children aged 2 months to 5 years.

What happens to the vessel wall at the microscopic level?

Microscopy reveals inflammation and tissue necrosis. Destruction can be localized exclusively in the inner layer (intima) or involve all layers of the vessel wall.

What is the probability of developing cardiovascular complications?

Severe cardiovascular consequences develop in approximately 20% of patients. They include aneurysm formation, thrombosis, myocardial infarction, and the risk of sudden death.

Home › Pathology › Kawasaki Disease

Kawasaki Disease

Syndromum lymphonodulare mucocutaneum

For medical students2 min readUpdated 2026-10-10

Kawasaki disease is a severe systemic condition characterized by inflammatory lesions of the blood vessels. In pathology, this process is classified as a systemic vasculitis that predominantly affects medium-sized arteries, causing life-threatening cardiovascular complications in infants and young children.

Patient ageChildren aged 2 months to 5 years

Vasculitis targetsMedium-sized arteries (coronary, renal)

Complication rateApproximately 20% of cases develop cardiac pathology

PathogenesisAutoantibodies to the endothelium and immune complexes

Epidemiology and Etiological Factors

The disease has a clearly defined high-risk age group, making it extremely important to study in pediatric pathology. In the vast majority of cases, the disease manifests in early childhood, with the bulk of patients being children between two months and five years of age.

Despite active research into this systemic vasculitis, the exact etiology of the disease remains unknown. To date, no single specific factor has been identified that can be called the definitive primary cause triggering the pathological process.

Pathogenesis: Immunological Dysfunction

Although the primary cause remains hidden, the mechanisms of tissue damage have been studied in detail. The pathogenesis is based on a severe immune system dysfunction that leads to an attack on the body's own tissues.

The process develops through the following mechanisms:

There is marked activation of cellular and humoral immunity, involving both T lymphocytes and B lymphocytes in the pathological cascade.
Circulating immune complexes are detected in the patient's bloodstream, exacerbating systemic inflammation.
The immune system actively produces autoantibodies specifically directed against the endothelium—the inner lining of blood vessels. This factor acts as the triggering mechanism for the destruction of the vessel wall.

Clinical and Morphological Features

The historical alternative name for the pathology is mucocutaneous lymph node syndrome. This accurately describes the macroscopic and clinical manifestations of the disease. Patients develop generalized lymphadenopathy (systemic enlargement of lymph nodes), specific skin lesions, and erosions of the mucous membranes.

However, the primary events unfold at the microscopic level. Histological examination of tissues (in the arteries of the skin, oral mucosa, heart, and other organs) reveals severe vasculitis. There is pronounced inflammation and necrosis of the vessel tissues. This destructive process may be limited to the innermost layer of the artery (intima) or aggressively spread across the entire thickness of the vessel wall. Due to necrosis, the wall loses its structural strength, inevitably leading to the formation of aneurysms—pathological arterial dilations.

Severe Cardiac Complications

Cardiovascular system (CVS) involvement is the most dangerous aspect of Kawasaki disease. Such complications develop in approximately 20% of affected children and determine the prognosis of the disease.

The pathological cascade in the heart includes the following conditions:

Asymptomatic dilation of cardiac arteries — the initial stage of vessel wall tone loss due to inflammation.
Coronary artery aneurysms — the formation of pronounced dilations at sites of vessel wall necrosis.
Thrombosis — damaged endothelium and altered blood flow within aneurysms provoke the formation of blood clots.
Myocardial infarction — a critical consequence of thrombosis resulting in the occlusion of coronary blood flow.
Sudden death — the most fatal outcome that can result from the aforementioned vascular catastrophes.

Mnemonic

To quickly memorize the clinical picture, always use the disease synonym: mucocutaneous lymph node syndrome. The name itself encodes the classic triad of external manifestations: erosive lesions of the mucous membranes, skin changes, and generalized lymphadenopathy.

Frequently asked questions

What clinical criteria are necessary to diagnose Kawasaki disease?: Kawasaki disease is diagnosed based on a combination of prolonged fever and five clinical sign categories, including bilateral bulbar conjunctival injection, oropharyngeal mucosal changes, peripheral extremity changes, rash, and cervical lymphadenopathy. A diagnosis of incomplete syndrome is also valid if cardiac involvement is present even without the full set of criteria.
Which infectious diseases are differentiated from Kawasaki disease in children?: In differential diagnosis, Kawasaki syndrome must be distinguished from several childhood infections, including scarlet fever, measles, and acute viral respiratory infections.
What extracardiac visceral manifestations can occur in Kawasaki disease?: In addition to core manifestations, Kawasaki disease may present with various extracardiac and visceral changes, such as generalized lymphadenopathy, skin lesions, mucosal erosions, and gastroenterological disorders including dyspepsia, abdominal pain, and transient hepatomegaly. Rare manifestations include central nervous system involvement (aseptic meningitis), pulmonary infiltrates, and orchitis (testicular edema).
Which blood vessels are primarily affected in this disease?: The pathological process predominantly affects medium-sized arteries. Of greatest clinical significance is the severe involvement of the coronary arteries of the heart and the renal arteries.
At what age are patients most susceptible to this vasculitis?: Kawasaki disease is a classic pediatric pathology. The absolute majority of affected individuals are young children aged 2 months to 5 years.
What happens to the vessel wall at the microscopic level?: Microscopy reveals inflammation and tissue necrosis. Destruction can be localized exclusively in the inner layer (intima) or involve all layers of the vessel wall.
What is the probability of developing cardiovascular complications?: Severe cardiovascular consequences develop in approximately 20% of patients. They include aneurysm formation, thrombosis, myocardial infarction, and the risk of sudden death.

Go deeper

Detailed mechanism of immune complex formation and circulation in systemic vasculitides
Histological features of intimal necrosis compared to total vessel wall involvement
Pathogenesis of coronary aneurysm formation secondary to autoimmune endothelial injury
Morphological picture of myocardial infarction in young children
The role of T and B lymphocytes in triggering autoimmune reactions against autologous blood vessels